AZD-5069

878385-84-3

12352005

H360

CXCR

Reference compound

GPCR/G Protein; Immunology/Inflammation

Cancer-programmed cell death

Cancer; Endocrinology

https://www.medchemexpress.com/AZD-5069.html

99.91

DMSO : 90 mg/mL (ultrasonic)

O=S(N1CCC1)(NC2=NC(SCC3=CC=CC(F)=C3F)=NC(O[C@H](C)[C@@H](O)CO)=C2)=O

C18H22F2N4O5S2

476.52

H360

[1]Norman P, et al. Evidence on the identity of the CXCR2 antagonist AZD-5069. Expert Opin Ther Pat. 2013 Jan;23 (1) :113-7.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

Phase 2

CXCR2